INDICATIONS AND USAGE:
Intravenous or Intramuscular Injection
When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows:
Endocrine Disorders
Primary or secondary adrenocortical insufficiency(hydrocortisone or cortisone is thedrug of choice; synthetic analogs may be used in conjunction with mineralocorticoidswhereapplicable; in infancy, mineralocorticoid supplementation is of particular importance)
Acute adrenocortical insufficiency(hydrocortisone or cortisone is the drug of choice;mineralocorticoid supplementation may be necessary, particularly when syntheticanalogs are used)
Preoperatively, and in the event of serious trauma or illness, in patients with knownadrenal insufficiency or when adrenocortical reserve is doubtful
Shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected
Congenital adrenal hyperplasia
Nonsuppurative thyroiditis
Hypercalcemia associated with cancer
Rheumatic Disorders
As adjunctive therapy for short-term administration(to tide the patient over an acuteepisode or exacerbation)in:
Post-traumatic osteoarthritis
Synovitis of osteoarthritis
Rheumatoid arthritis, including juvenile rheumatoid arthritis(selected cases may requirelow-dose maintenance therapy)
Acute and subacute bursitis
Epicondylitis
Acute nonspecific tenosynovitis
Acute gouty arthritis
Psoriatic arthritis
Ankylosing spondylitis
Collagen Diseases
During an exacerbation or as maintenance therapy in selected cases of:
Systemic lupus erythematosus
Acute rheumatic carditis
Dermatologic Diseases
Pemphigus
Severe erythema multiforme (Stevens-Johnson syndrome)
Exfoliative dermatitis
Bullous dermatitis herpetiformis
Severe seborrheic dermatitis
Severe psoriasis
Mycosis fungoides
Allergic States
Control of severe or incapacitating allergic conditions intractable to adequate trials ofconventional treatment in:
Bronchial asthma
Contact dermatitis
Atopic dermatitis
Serum sickness
Seasonal or perennial allergic rhinitis
Drug hypersensitivity reactions
Urticarial transfusion reactions
Acute noninfectious laryngeal edema (epinephrine is the drug of first choice)
Ophthalmic Diseases
Severe acute and chronic allergic and inflammatory processes involving the eye, such as:
Herpes zoster ophthalmicus
Iritis, iridocyclitis
Chorioretinitis
Diffuse posterior uveitis and choroiditis
Optic neuritis
Sympathetic ophthalmia
Anterior segment inflammation
Allergic conjunctivitis
Keratitis
Allergic corneal marginal ulcers
Gastrointestinal Diseases
To tide the patient over a critical period of the disease in:
Ulcerative colitis(Systemic therapy)
Regional enteritis(Systemic therapy)
Respiratory Diseases
Symptomatic sarcoidosis
Berylliosis
Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy Loefflers syndrome not manageable by other means
Aspiration pneumonitis
Hematologic Disorders
Acquired(autoimmune hemolytic anemia Idiopathic thrombocytopenic purpura inadults(IV only; IM administration is contraindicated)
Secondary thrombocytopenia in adults
Erythroblastopenia(RBC anemia)
Congenital(erythroid hypoplastic anemia
Neoplastic Diseases
For palliative management of:
Leukemias and lymphomas in adults
Acute leukemia of childhood
Edematous States
To induce diuresis or remission of proteinuria in the nephrotic syndrome, withouturemia, of the idiopathic type, or that due to lupus erythematosus
Miscellaneous
Tuberculous meningitis with subarachnoid block or impending block when usedconcurrently with appropriate antituberculous chemotherapy richinosis with neurologicor myocardial involvement
Diagnostic testing of adrenocortical hyperfunction
Cerebral Edema associated with primary or metastatic brain tumor, craniotomy, or head injury.
Use in cerebral edema is not a substitute for careful neurosurgical evaluation and definitive management such as neurosurgery or other specific therapy.
By Intra-articular or Soft Tissue Injection
As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:
Synovitis of osteoarthritis
Rheumatoid arthritis
Acute and subacute bursitis
Acute gouty arthritis
Epicondylitis
Acute nonspecific tenosynovitis
Post-traumatic osteoarthritis
By Intralesional Injection
Keloids
Localized hypertrophic, infiltrated, inflammatory lesions of: lichen planus, psoriatic plaques, granuloma annulare and lichen simplex chronicus (neurodermatitis)
Discoid lupus erythematosus
Necrobiosis lipoidica diabeticorum
Alopecia areata
May also be useful in cystic tumors of an aponeurosis or tendon (ganglia)